Core Viewpoint - The company Xiaofang Pharmaceutical announced a cash dividend plan for the first half of 2025, proposing a distribution of 7 yuan per 10 shares, totaling 112 million yuan, which represents 93.02% of its net profit, with a dividend yield of 2.47% based on the average trading price [2][3]. Company Summary - Xiaofang Pharmaceutical's revenue for the first half of 2025 reached 270 million yuan, reflecting a year-on-year growth of 3.06%, while net profit was 121 million yuan, up 1.69% year-on-year, resulting in a basic earnings per share of 0.75 yuan [2]. - This marks the second cash distribution since the company's listing, with the previous distribution in December 2024 being 15 yuan per 10 shares, totaling 241 million yuan and a dividend yield of 5.46% [2][3]. Industry Summary - In the pharmaceutical and biotechnology sector, 35 companies have announced their dividend plans for the first half of 2025, with WuXi AppTec leading with a cash distribution of 1 billion yuan, followed by Dong-E E-Jiao and China Resources Sanjiu with distributions of 817 million yuan and 751 million yuan, respectively [3]. - Xiaofang Pharmaceutical's cash distribution ranks among the notable payouts in the industry, with a significant proportion of its net profit allocated to dividends [3][4].
小方制药2025半年度拟派1.12亿元红包